Slower Progression Rates in Lower Limb-Onset ALS
Journal of Clinical Medicine · 18.04.2026 · 15 (8) · 3096
DOI: 10.3390/jcm15083096 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 18.04.2026. Verfasst von Yehuda Shovman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 91120, Israel. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Perner Yaacov memorial fund.
Abstract (Originalsprache)
Objectives
The aim of this study was to assess the differences in diagnostic delay and disease progression in people with ALS (PALS) based on site of onset.
Methods
A retrospective analysis of prospectively collected data was performed, including all PALS seen in the ALS clinic in the Hadassah Medical Center between January 2009 and March 2022. PALS were divided to three groups based on site of onset (upper limb onset—ULO, lower limb onset—LLO, or bulbar onset—BO). A linear mixed-effects model was constructed with the following variables: diagnostic delay, site of onset, age of onset and time since the initial visit. The model was applied to the ALSFRS-R total score and the bulbar and motor subscales.
Results
Data from 1255 visits of 281 PALS were included in the study. PALS with LLO had longer diagnostic delays than PALS in the BO group. Slower decline of total ALSFRS-R score was observed in younger PALS, and in PALS with LLO when compared with PALS with BO or ULO. The slower decline of ALSFRS-R in PALS with LLO was due to a slower decline in the motor subscale. Longer diagnostic delays were associated with lower total ALSFRS-R scores at the initial visit and with slower rates of decline.
Conclusions
Comparison among PALS with ULO, LLO and BO revealed differences in the diagnostic delay and in the rate of functional decline, suggesting that differentiating between ULO and LLO ALS may be useful in the stratification of PALS in clinical trials.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 91120, Israel.
- The Concern Foundation Laboratories at the Lautenberg Center for Immunology and Cancer Research, Israel-Canada Medical Research Institute, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 91120, Israel.
ORCID-Profile: Marc Gotkine
Förderung
- Perner Yaacov memorial fund
Zitieren
APA
Shovman, Y., Lerner, Y., & Gotkine, M. (2026). Slower Progression Rates in Lower Limb-Onset ALS. Journal of Clinical Medicine, 15(8), 3096. https://doi.org/10.3390/jcm15083096
Vancouver
Shovman Y, Lerner Y, Gotkine M. Slower Progression Rates in Lower Limb-Onset ALS. Journal of Clinical Medicine. 2026;15(8):3096. doi:10.3390/jcm15083096
BibTeX
@article{Shovman2026,
author = {Shovman, Yehuda and Lerner, Yossef and Gotkine, Marc},
title = {Slower Progression Rates in Lower Limb-Onset ALS},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {8},
pages = {3096},
doi = {10.3390/jcm15083096}
}
EUVIMED